e-learning
resources
Vienna 2012
Monday, 03.09.2012
Viral infections and rare respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: Induction of protective T cell immunity against influenza using a novel peptide vaccine
T. Wilkinson, O. Pleguezuelos, S. Robinson, G. Stoloff, R. Lambkin- Williams, J. Oxford, A. Mann, A. Gilbert, W. Caparros-Wanderley (Southampton, London, United Kingdom)
Source:
Annual Congress 2012 - Viral infections and rare respiratory infections
Session:
Viral infections and rare respiratory infections
Session type:
Thematic Poster Session
Number:
2534
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Wilkinson, O. Pleguezuelos, S. Robinson, G. Stoloff, R. Lambkin- Williams, J. Oxford, A. Mann, A. Gilbert, W. Caparros-Wanderley (Southampton, London, United Kingdom). LATE-BREAKING ABSTRACT: Induction of protective T cell immunity against influenza using a novel peptide vaccine. Eur Respir J 2012; 40: Suppl. 56, 2534
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
ERS short guidelines on COVID-19 management
Influenza vaccination: protecting the most vulnerable
Understanding new vaccines for SARS-CoV-2 and their regulation
Related content which might interest you:
CD4+ T cell responses mediate protective immunity to influenza in the absence of protective antibody
Source: Annual Congress 2010 - Mechanisms of respiratory infections
Year: 2010
MAIT cells contribute to a protective antiviral innate response to influenza infection
Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Year: 2018
Impact of influenza antigen specific T cell responses on severity of viral infection in humans
Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection
Year: 2009
Monitoring the kinetics of a vaccine-induced T-cell response after H1N1 influenza vaccination
Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects
Year: 2010
Co-administration of vaccination with DNA encoding T cell epitope on the Der p and BCG inhibited allergic responses in mice
Source: Eur Respir J 2003; 22: Suppl. 45, 483s
Year: 2003
Mucosal immunity and novel tuberculosis vaccine strategies: route of immunisation-determined T-cell homing to restricted lung mucosal compartments
Source: Eur Respir Rev 2015; 24: 356-360
Year: 2015
The vaccination with DNA encoding T cell epitope on the Der p inhibited allergic responses in mice
Source: Eur Respir J 2002; 20: Suppl. 38, 28s
Year: 2002
Analysis of adaptive CD8+ T cell responses to Influenza A Virus in COPD patients
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020
LSC Abstract – The expression and function of BPIFA1 in the pulmonary innate immune response to influenza A virus infection
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015
Mucosal immunity and novel vaccines against tuberculosis
Source: Lung Science Conference 2015
Year: 2015
Does BCG revaccination lead to enhanced protective immunity against tuberculosis? A study using surrogate markers
Source: Annual Congress 2005 - Epidemiology and control of tuberculosis and LTBI
Year: 2005
Infection with influenza A virus leads to mast cell degranulation in mice
Source: Eur Respir J 2004; 24: Suppl. 48, 658s
Year: 2004
RCT Abstract - Ad26.COV2.S induces SARS-CoV-2 spike protein-specific cellular immunity and humoral immune responses that cover variants of concern
Source: Virtual Congress 2021 – Challenges of COVID-19 management at short and long-term
Year: 2021
LATE-BREAKING ABSTRACT: The critical role of interferon-gamma signaling in the respiratory immune response to influenza infection
Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment
Year: 2013
Do antimicrobial peptides shape the adaptive immune response?
Source: Annual Congress 2005 - Interaction between innate and adaptive immunity in lung disease
Year: 2005
Prime-boost, double-dose immunization and immunity to influenza vaccination in COPD
Source: Virtual Congress 2021 – Pneumonia
Year: 2021
Susceptibility to asthma exacerbation induced by superantigen is critically dependent on bystander mucosal Vβ8 TCR T cells in TH2 immune mice
Source: Eur Respir J 2001; 18: Suppl. 33, 19s
Year: 2001
State of the art in vaccine development against TB
Source: Eur Respir Mon 2012; 58: 59-71
Year: 2012
Immunological responses to influenza infection
Source: Annual Congress 2006 - Influenza: from avian flu to pandemia?
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept